长沙USDT收款|【唯一TG:@heimifeng8】|Telegram账号盗取破解技术✨谷歌搜索留痕排名,史上最强SEO技术,20年谷歌SEO经验大佬✨Eli Lilly's new drug helps lose excess weight and lowers blood sugar levels
A large-scale trial of a daily weight-loss pill has found that it helps people shed extra pounds and lower blood sugar levels, making it a contender in a new wave of drugs that fight obesity and diabetes, The Guardian reports.
People who took orforglypron at a 36-mg dose lost an average of 7.3 kilograms over nine months, according to the results of a phase 3 clinical trial reported by the drug's maker Eli Lilly on Thursday.
The study, which involved 559 obese people with type 2 diabetes from the United States, China, India, Japan and Mexico, also showed that daily use of the pills lowered blood sugar levels, in some cases dropping them to below the official threshold for diabetes.
Orforglypron is a daily tablet version of the GLP-1 agonist, a drug used in popular weight-loss injections such as Ozempic and Wegovy.
In a statement accompanying the results, the company said the drug met expectations for safety, tolerability, glucose control and weight loss.
Although the popularity of weight loss pills has skyrocketed, health officials believe that daily pills of the drug will allow more people to control their weight and blood sugar levels.